Precision AI Logo
recision allele.Dx
PRECISION IN EVERY ALLELE
Talk to us

Precision in
every allele.

High-end next-generation sequencing solutions designed to turn complex genomic signals into clear, actionable insights for cancer care.

High-End NGS Deep coverage. Greater insight.
Pan-Cancer Panels Comprehensive molecular profiling.
Rapid Turnaround Actionable reports in record time.
Explore diagnostic panels Discover our approach
25+ Diagnostic Panels
Multiple Tumor Types
NGS DNA • RNA • ctDNA
Actionable Clinical Insights
Stunning DNA
From
Sequence
to Better
Outcomes
DETECT UNDERSTAND MATCH TREAT IMPROVE
Genomic Profiling SNV • CNV • MSI
Deep Sequencing High resolution detection
Clinical Support Therapy matching
Personalized Oncology For better outcomes
SNV
CNV
MSI
FUSION
TMB
HRD

Our Vision

Transforming precision oncology through accessible, high-resolution genomic diagnostics. We aim to empower oncologists and clinicians worldwide with actionable, comprehensive molecular insights that guide individualized patient care and improve clinical outcomes across all tumor types.

Precision Oncology & Genomic Diagnostics

Comprehensive biomarker profiling and clinical decision support designed for personalized cancer therapy.

Comprehensive Solid Tumor Profiling

  • Multi-gene Next-Generation Sequencing (NGS) panels targeting actionable driver mutations.
  • Detects key single nucleotide variants (SNVs), indels, copy number variations (CNVs), and gene fusions.
  • Guides precision treatment access tailored to tumor molecular profile.

Liquid Biopsy & ctDNA Analysis

  • Non-invasive, blood-based genomic profiling for circulating tumor DNA.
  • Enables early detection and ongoing treatment response tracking.
  • Minimal Residual Disease (MRD) monitoring for early relapse detection.

Hereditary Cancer Screening

  • Targeted germline panel testing for inherited predisposition genes (e.g., BRCA1/2, Lynch syndrome).
  • Comprehensive risk assessment for familial cancer syndromes.
  • Empowers proactive screening and risk-reduction strategies.

Hematologic Malignancy Panels

  • Specialized genomic profiling panels for leukemia, lymphoma, and myeloma.
  • Informs risk stratification, diagnosis, and targeted regimen selection.
  • Monitors clonal evolution throughout therapeutic interventions.

Bioinformatics & Clinical Decision Support

Our proprietary pipeline matches identified variants with key open clinical trials, FDA-approved targeted therapies, and guidelines to generate clear, actionable reports for oncologists and tumor boards.

< 0.5% ALLELE FREQUENCY SENSITIVITY
4-21 Days SAMPLE-TO-REPORT TAT
CAP / NABL QUALITY ACCREDITATIONS

Our Diagnostic Panels

A comprehensive menu of testing solutions for all clinical scenarios.

# PANEL TEST COVER SAMPLE TYPE TAT
1 Somatic Whole Exome Sequencing NGS-All Human ~23000 genes (300x coverage) FFPE Tissue Block 16 Days
2 Somatic Comprehensive Genomics Profiling (MSI+TMB+HRD) NGS-1080 DNA Genes +104 fusion partners MSI+TMB+HRD FFPE Tissue Block 16 Days
3 Somatic Lung Gene panel 126 Genes and MSI FFPE Tissue Block 16 Days
4 Somatic Pan-Solid Tumour Panel 126 Genes and MSI FFPE Tissue Block 16 Days
5 Somatic Sarcoma Gene Panel NGS-571 DNA Genes + 2660 RNA fusion partners, TMB and MSI FFPE Tissue Block 16 Days
6 Somatic Endometrium Panel 51 HRR Genes FFPE Tissue Block 16 Days
7 Somatic Targeted Lung cancer Gene Panel 12 Genes FFPE Tissue Block 16 Days
8 Somatic Targeted Breast Cancer Gene Panel 25 Genes FFPE Tissue Block 16 Days
9 Somatic Targeted Colorectal Cancer Gene Panel 41 genes + 11 MSI Markers FFPE Tissue Block 16 Days
10 Somatic Targeted Ovarian Cancer Gene Panel 26 Genes FFPE Tissue Block 16 Days
11 Somatic Targeted endometrium Cancer Gene Panel 34 Genes FFPE Tissue Block 16 Days
12 Somatic 96hrs Solid Tumour Panel (Oncomine Precision Assay) 50 key oncology genes Pan Cancer FFPE Tissue Block or 10ml Blood in Streck Tube / CSF or Pleural Fluid in EDTA Tube 4 Days
13 Somatic 96hrs Myeloid Panel (Oncomine Myeloid Assay) DNA Panel: Hotspot Gene (23) Full Gene (17) RNA Panel: Expression Gene (5) Expression Control Gene (5) Fusion Driver Gene (29) 3ml Bone marrow Aspirate in EDTA Tube 4 Days
14 Somatic Comprehensive Leukaemia Panel (ALL/AML) NGS-98 DNA Genes + 119 RNA Fusions 3ml Bone Marrow Aspirate in EDTA Tube 16 Days
15 Comprehensive Pan- Liquid Biopsy (CtDNA) 126 Genes and MSI 10ml Blood in Streck Tube / CSF or Pleural Fluid in EDTA Tube 16 Days
16 Germline Oncomine BRCA 1 and BRCA2 BRCA 1 and BRCA2 - Full Gene Whole Blood in EDTA Tube 16 Days
17 Germline Whole Exome Sequencing NGS-All Human ~23000 genes (100x coverage) Whole Blood in EDTA Tube 16 Days
18 Germline Comprehensive Hereditary Gene Panel 74 Genes Whole Blood in EDTA Tube 16 Days
19 Germline BRCA 1 & 2 deletion/duplication by MLPA BRCA 1 and BRCA2 - Full Gene Whole Blood in EDTA Tube 10 Days
20 PCR- EGFR Mutation Panel Exon 18 19 20 21-Hotspots FFPE Tissue Block or 10ml Blood In Streck Tube 2 Days
21 PCR- KRAS Mutation Panel Exon 2 3 & 4 -Hotspots FFPE Tissue Block 2 Days
22 PCR- NRAS Mutation Panel Exon 2 3 & 4 -Hotspots FFPE Tissue Block 2 Days
23 PCR- BRAF Mutation Panel Exon 15 V600E FFPE Tissue Block 2 Days
24 PCR- DPYD Mutation Panel DPYD*2A/DPYD*13/D949V/IVS10 /DPYD*6 Whole Blood in EDTA Tube 2 Days

Advanced Technology

Powered by cutting-edge sequencing systems for unparalleled precision.

Thermo Fisher Genexus

The first fully integrated next-generation sequencing platform featuring an automated specimen-to-report workflow.

nCounter Analysis System

Advanced digital counting of nucleic acids for highly multiplexed, direct profiling of individual molecules.

Resources & Insights

Stay updated with the latest in precision oncology, case studies, and clinical research.

Case Study

Clinical Integration of WGS in Solid Cancers

Real-world studies demonstrating high success rates in generating actionable diagnostic reports.

Publication

Multi-Modal AI in Precision Oncology

Integrating genomics with medical imaging and EHR for superior patient stratification.

Webinar

Spatial Genomics Redefining Diagnostics

Identifying tumor subtypes and cryptic histological regions previously undetectable.

Ready to advance
precision medicine?

Whether you're a hospital, a clinic, or an independent practitioner — we have a partnership tier designed for you.

  • partnerships@precisionalleleDx.com
  • +91 12345 67890
  • Hyderabad, Telangana, India